Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hepatocyte plasma membrane is a highly organized cellular boundary that facilitates the liver's diverse metabolic and secretory functions. Lipid rafts are dynamic, cholesterol- and sphingolipid-rich microdomains within this membrane that serve as essential platforms for the assembly of signaling complexes and the regulation of membrane protein trafficking (Lingwood & Simons, 2010, Science). These structures are particularly significant in infectious diseases, as they are exploited by pathogens such as the Hepatitis C virus and Plasmodium species for cellular entry (Kapoor et al., 2011, J Biol Chem; Silvie et al., 2003, Nature Medicine). Additionally, lipid rafts play a role in metabolic signaling, influencing the activity of the insulin receptor and various bile acid transporters like the sodium/taurocholate cotransporting polypeptide (NTCP) (Vial & Schneiter, 2002, Progress in Lipid Research). While the membrane and its rafts are not traditional single-molecule drug targets, they are pharmacologically relevant sites where drugs like cholesterol-depleting agents can disrupt pathological processes (Zhuang et al., 2005, J Lipid Res). However, the therapeutic utility of targeting these domains is limited by a lack of tissue specificity and the risk of interfering with fundamental cellular signaling pathways.
Disruption of lipid raft assembly through cholesterol depletion or sequestration, thereby inhibiting raft-associated signaling and pathogen entry.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte plasma membrane and lipid rafts.